Estrogen induces RAD51C expression and localization to sites of DNA damage

Area of Science:

• Genetics
• Genomics
• Cancer Biology

Background:

• Homologous recombination (HR) repairs DNA double-strand breaks (DSBs), maintaining genome stability.
• RAD51 proteins are crucial for HR; their dysregulation contributes to cancer.
• Estrogen is implicated as a DNA-damaging agent causing DSBs.

Purpose of the Study:

• To investigate the role of estrogen receptor alpha (ERα) in regulating RAD51C expression in breast cancer.
• To explore the functional consequences of estrogen-induced RAD51C regulation on DNA repair and genomic instability.
• To examine the clinical relevance of RAD51C and ERα status in breast cancer outcomes.

Main Methods:

• Analysis of ERα-positive breast cancer cells.
• Estrogen treatment and manipulation of ERα signaling (anti-estrogens, siRNA).
• Quantitative assessment of RAD51C expression and nuclear foci formation.
• Correlation analysis of RAD51C expression and ERα status with clinical outcomes.

Main Results:

• Estrogen upregulates RAD51C expression in an ERα-dependent manner.
• Estrogen promotes RAD51C assembly into nuclear foci at DSBs.
• Disruption of ERα signaling inhibits estrogen-induced RAD51C upregulation.
• A correlation exists between high RAD51C expression, ERα status, and worse clinical outcomes in breast cancer.

Conclusions:

• Estrogen plays a significant role in regulating DNA repair capacity in ERα-positive breast cancer via RAD51C.
• Dysregulation of this pathway may contribute to genomic instability and cancer progression.
• RAD51C and ERα status are potential prognostic markers for breast cancer.